Schizophrenic symptoms improve with apomorphine

Carol A. Tamminga, Martin H. Schaffer, Robert C. Smith, John M. Davis

Research output: Contribution to journalArticlepeer-review

193 Scopus citations


Eighteen chronic schizophrenic patients received subcutaneous doses of apomorphine, a dopamine receptor agonist, and of placebo in separate trials. A significant improvement in psychotic symptoms occurred after apomorphine compared to placebo. The results are interpreted as a consequence of presynaptic dopamine receptor activation by apomorphine with a subsequent decrease in dopamine-mediated neural transmission.

Original languageEnglish (US)
Pages (from-to)567-568
Number of pages2
Issue number4341
StatePublished - 1978

ASJC Scopus subject areas

  • General


Dive into the research topics of 'Schizophrenic symptoms improve with apomorphine'. Together they form a unique fingerprint.

Cite this